Kiniksa Pharmaceuticals International (KNSA) Enterprise Value: 5.393B

Kiniksa Pharmaceuticals International Plc (KNSA)

75.79 +0.57 (+0.76%) USD | NASDAQ | Oct 02, 16:00

75.72 -0.07 (-0.09%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2018. Start Trial.

Date	Value
October 02, 2026	5.393B
October 01, 2026	5.349B
September 30, 2026	5.301B
September 29, 2026	5.388B
September 28, 2026	5.417B
September 25, 2026	5.338B
September 24, 2026	5.358B
September 23, 2026	5.416B
September 22, 2026	5.565B
September 21, 2026	5.576B
September 18, 2026	5.506B
September 17, 2026	5.669B
September 16, 2026	5.536B
September 15, 2026	5.343B
September 14, 2026	5.455B
September 11, 2026	5.430B
September 10, 2026	5.447B
September 09, 2026	5.606B
September 08, 2026	5.494B
September 04, 2026	5.558B
September 03, 2026	5.758B
September 02, 2026	5.713B
September 01, 2026	5.665B
August 31, 2026	5.615B
August 28, 2026	5.572B

Date	Value
August 27, 2026	5.706B
August 26, 2026	5.618B
August 25, 2026	5.737B
August 24, 2026	5.673B
August 21, 2026	5.646B
August 20, 2026	5.602B
August 19, 2026	5.784B
August 18, 2026	5.682B
August 17, 2026	5.657B
August 14, 2026	5.468B
August 13, 2026	5.552B
August 12, 2026	5.577B
August 11, 2026	5.550B
August 10, 2026	5.451B
August 07, 2026	5.414B
August 06, 2026	5.449B
August 05, 2026	5.572B
August 04, 2026	5.409B
August 03, 2026	5.207B
July 31, 2026	5.280B
July 30, 2026	5.581B
July 29, 2026	5.793B
July 28, 2026	5.678B
July 27, 2026	4.437B
July 24, 2026	4.383B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks